Experts say only a few university health systems have launched such comprehensive plans around AI, with the potential to impact millions of patients, students and faculty.
While Houston’s largest hospitals are all adopting AI in radiology, some move slower than others, citing high costs and uncertainty about its potential to improve health outcomes.
Today, the scale at which most compounding pharmacies produce drugs — and the frequency of problems arising from their products — remains largely unknown.
We began reporting on drug quality concerns at Empower Pharmacy back in April 2025. We spent the next year examining Empower's efforts to create a new pharmaceutical supply chain.
Compounding pharmacies don't have to disclose reports of patient harm to the FDA. Nor do they have to abide by the stringent manufacturing standards that apply to traditional drug manufacturers.
Compounded drugs sold for cash prices don’t generate billing records that would allow regulators to track basic information, like who is taking the drug and what happens after treatment.
Even after numerous FDA warnings, the agency hasn’t stopped Empower Pharmacy from producing drugs at a scale rarely — if ever — seen in the compounding pharmacy industry.
According to internal financial records, the pharmacy dispensed nearly 3 million individual prescriptions to patients nationwide during the first 10 months of 2024, drawing $311 million in...
Multiple experts who reviewed the donation say the payment could qualify as a conflict because it has the potential to influence prescribing decisions.
